Q3 2022 EPS Estimates for Henry Schein, Inc. Reduced by Jefferies Financial Group (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC – Get Rating) – Analysts at Jefferies Financial Group reduced their Q3 2022 EPS estimates for Henry Schein in a research report issued to clients and investors on Wednesday, August 3rd. Jefferies Financial Group analyst B. Couillard now anticipates that the company will post earnings of $1.14 per share for the quarter, down from their previous forecast of $1.20. The consensus estimate for Henry Schein’s current full-year earnings is $4.85 per share. Jefferies Financial Group also issued estimates for Henry Schein’s Q1 2023 earnings at $1.27 EPS, Q2 2023 earnings at $1.21 EPS, Q3 2023 earnings at $1.31 EPS, Q4 2023 earnings at $1.42 EPS and FY2023 earnings at $5.20 EPS.

Henry Schein (NASDAQ:HSIC – Get Rating) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $1.16 EPS for the quarter, meeting the consensus estimate of $1.16. Henry Schein had a net margin of 5.11% and a return on equity of 15.56%. The firm had revenue of $3.03 billion for the quarter, compared to the consensus estimate of $3.12 billion. During the same period in the previous year, the company earned $1.11 earnings per share. The company’s quarterly revenue was up 2.1% on a year-over-year basis.

Several other research firms also recently commented on HSIC. Robert W. Baird downgraded shares of Henry Schein from an “outperform” rating to a “neutral” rating and decreased their price target for the company from $103.00 to $88.00 in a research note on Tuesday, June 14th. Piper Sandler decreased their price target on shares of Henry Schein from $100.00 to $96.00 in a research note on Tuesday. Barrington Research decreased their price target on shares of Henry Schein from $102.00 to $99.00 and set an “outperform” rating on the stock in a research note on Wednesday. Credit Suisse Group decreased their price target on shares of Henry Schein from $100.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday. Finally, William Blair restated a “market perform” rating on shares of Henry Schein in a research note on Tuesday, May 3rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, Henry Schein presently has an average rating of “Hold” and a consensus target price of $87.14.

Henry Schein Price Performance

NASDAQ:HSIC opened at $75.38 on Thursday. Henry Schein has a one year low of $70.25 and a one year high of $92.68. The company has a market cap of $10.41 billion, a P/E ratio of 16.18, a P/E/G ratio of 2.01 and a beta of 0.75. The firm’s fifty day moving average price is $77.98 and its two-hundred day moving average price is $81.97. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.83 and a quick ratio of 0.91.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. MQS Management LLC bought a new position in shares of Henry Schein in the second quarter worth about $597,000. M&T Bank Corp increased its stake in shares of Henry Schein by 7.6% in the second quarter. M&T Bank Corp now owns 11,734 shares of the company’s stock valued at $830,000 after buying an additional 827 shares during the period. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Henry Schein in the second quarter valued at approximately $214,000. Zions Bancorporation N.A. increased its stake in shares of Henry Schein by 21.9% in the second quarter. Zions Bancorporation N.A. now owns 14,096 shares of the company’s stock valued at $1,082,000 after buying an additional 2,530 shares during the period. Finally, Riverwater Partners LLC acquired a new position in shares of Henry Schein in the second quarter valued at approximately $289,000. Institutional investors own 94.30% of the company’s stock.

Insider Buying and Selling

In related news, EVP Gerald A. Benjamin sold 11,489 shares of the company’s stock in a transaction dated Thursday, May 26th. The shares were sold at an average price of $85.47, for a total transaction of $981,964.83. Following the completion of the sale, the executive vice president now owns 95,616 shares of the company’s stock, valued at $8,172,299.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.00% of the stock is currently owned by company insiders.

Henry Schein Company Profile

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.